ciprofloxacin has been researched along with Bronchial Pneumonia in 12 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-nine adult patients with cystic fibrosis who had chronic bronchopulmonary infection were randomly assigned to receive 750 or 1,000 mg of oral ciprofloxacin every 12 hours for two weeks." | 9.06 | Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. ( Chartrand, SA; Hilman, BC; Marks, MI; Shalit, I; Stutman, HR, 1987) |
| "Moxifloxacin has potent bactericidal activity against Streptococcus pneumoniae; a major causative organism of lower respiratory tract infections." | 7.80 | Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios. ( Noreddin, AM; Salem, AH, 2014) |
| "Twenty-nine adult patients with cystic fibrosis who had chronic bronchopulmonary infection were randomly assigned to receive 750 or 1,000 mg of oral ciprofloxacin every 12 hours for two weeks." | 5.06 | Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. ( Chartrand, SA; Hilman, BC; Marks, MI; Shalit, I; Stutman, HR, 1987) |
| "Moxifloxacin has potent bactericidal activity against Streptococcus pneumoniae; a major causative organism of lower respiratory tract infections." | 3.80 | Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios. ( Noreddin, AM; Salem, AH, 2014) |
| "The efficacy and safety of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections was evaluated in 72 patients suffering from upper urinary tract infection (19 patients), deep soft tissue infection (16), chronic osteomyelitis (12), abscess (7), chronic otitis media (6), otitis externa (3) and bronchopneumonia (9)." | 3.67 | Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. ( Daikos, GK; Daphnis, E; Dendrinos, C; Galanakis, N; Giamarellou, H; Stefanou, J, 1986) |
| "Achalasia is a common adult disorder that rarely manifests in children and infrequently can be associated with pulmonary nontuberculous mycobacteria infections." | 1.37 | Achalasia and mycobacterium goodii pulmonary infection. ( Borrás-Salvador, R; Franco, J; Martí-Obiol, R; Martínez-González, D; Muñoz, C; Navarro-Ortega, D, 2011) |
| "Ciprofloxacin was given at a dose of 200 mg over 30 min by using an automatic pump." | 1.29 | Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia. ( Bruguerolle, B; De Micco, P; Gouin, F; Mallet, MN; Martin, C; Papazian, L; Saux, P, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salem, AH | 1 |
| Noreddin, AM | 1 |
| Martínez-González, D | 1 |
| Franco, J | 1 |
| Navarro-Ortega, D | 1 |
| Muñoz, C | 1 |
| Martí-Obiol, R | 1 |
| Borrás-Salvador, R | 1 |
| Cantón, R | 1 |
| Cobos, N | 1 |
| de Gracia, J | 1 |
| Baquero, F | 1 |
| Honorato, J | 1 |
| Gartner, S | 1 |
| Alvarez, A | 1 |
| Salcedo, A | 1 |
| Oliver, A | 1 |
| García-Quetglas, E | 1 |
| Beuscart, C | 1 |
| Leroy, O | 1 |
| Chidiac, C | 1 |
| Houriez, S | 1 |
| Caillaux, M | 1 |
| Beaucaire, G | 1 |
| Mouton, Y | 1 |
| Adzhimuradova, DK | 1 |
| Sokolova, VI | 1 |
| Smirnova, LB | 1 |
| Orlov, VA | 1 |
| Saux, P | 1 |
| Martin, C | 1 |
| Mallet, MN | 1 |
| Papazian, L | 1 |
| Bruguerolle, B | 1 |
| De Micco, P | 1 |
| Gouin, F | 1 |
| Irwin, PJ | 1 |
| Whithear, K | 1 |
| Lavelle, RB | 1 |
| Parry, BW | 1 |
| Krcméry, V | 1 |
| Fuchsberger, P | 1 |
| Trupl, J | 1 |
| Sufliarsky, J | 1 |
| Spanik, S | 1 |
| Koza, I | 1 |
| Kusenda, Z | 1 |
| Korec, S | 1 |
| Svec, J | 1 |
| Durkovic, P | 1 |
| Giamarellou, H | 2 |
| Daphnis, E | 2 |
| Dendrinos, C | 2 |
| Daikos, GK | 2 |
| Galanakis, N | 1 |
| Stefanou, J | 1 |
| Shalit, I | 1 |
| Stutman, HR | 1 |
| Marks, MI | 1 |
| Chartrand, SA | 1 |
| Hilman, BC | 1 |
1 review available for ciprofloxacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cep | 2005 |
3 trials available for ciprofloxacin and Bronchial Pneumonia
| Article | Year |
|---|---|
[A new formulation of ciprofloxacin with retarded release in therapy of patients with bronchopulmonary diseases].
Topics: Adult; Aged; Anti-Infective Agents; Bronchopneumonia; Ciprofloxacin; Drug Administration Schedule; F | 2006 |
Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication.
Topics: Adult; Agranulocytosis; Bronchopneumonia; Catheterization; Ceftazidime; Ciprofloxacin; Drug Therapy, | 1992 |
Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.
Topics: Adolescent; Adult; Bronchopneumonia; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Femal | 1987 |
8 other studies available for ciprofloxacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios.
Topics: Area Under Curve; Bronchopneumonia; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, B | 2014 |
Achalasia and mycobacterium goodii pulmonary infection.
Topics: Adolescent; Anti-Bacterial Agents; Bronchopneumonia; Ciprofloxacin; Doxycycline; Esophageal Achalasi | 2011 |
Treatment of bronchopulmonary infections by ciprofloxacin in an intensive care unit. Correlation between serum and bronchial concentrations and bacteriological results.
Topics: Anti-Bacterial Agents; Bronchopneumonia; Ciprofloxacin; Humans; Intensive Care Units; Pneumonia, Bac | 1989 |
Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.
Topics: Aged; Bronchi; Bronchopneumonia; Chromatography, High Pressure Liquid; Ciprofloxacin; Cross Infectio | 1994 |
[Management of infection in respiratory tract diseases].
Topics: Amoxicillin; Bacterial Infections; Bronchitis; Bronchopneumonia; Child; Ciprofloxacin; Drug Costs; H | 1995 |
Acute bronchopneumonia associated with Mycobacterium fortuitum infection in a dog.
Topics: Acute Disease; Animals; Anti-Infective Agents; Bronchopneumonia; Ciprofloxacin; Dog Diseases; Dogs; | 2000 |
Experience with ciprofloxacin in the treatment of various infections caused mainly by Pseudomonas aeruginosa.
Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Bronchopneumonia; Child; Ciprofloxacin; Fema | 1985 |
Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.
Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchopneumonia; Chi | 1986 |